Federal Bid

Last Updated on 12 Mar 2017 at 8 AM
Special Notice
University Mississippi

Neurotherapeutic Resuscitation Research

Solicitation ID 10934241-Neurotherapeutic
Posted Date 10 Feb 2017 at 7 PM
Archive Date 12 Mar 2017 at 5 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office U.S. Army Medical Research Acquisition Activity
Agency Department Of Defense
Location University Mississippi United states
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis, IAW FAR 6.302-1(a), with the University of Pittsburgh as the only responsible source that can provide Walter Reed Army Institute of Research for evaluation of neurotherapeutic resuscitation strategies in polytrauma associated with traumatic brain injury through a specialized mouse model developed at the University.


1.0 SCOPE OF WORK: This Statement of Work (SOW) defines the procurement of the technical expertise and support services necessary to refine animal models of military relevant brain injury by better understanding the co-morbidities during the sub-acute and chronic timeframe after injury. This work supports the mission of the Brain Trauma, Neuroprotection and Neurorestoration (BTNN) Branch, Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research (WRAIR).

2.0 BACKGROUND: The mission of the Walter Reed Army Institute of Research (WRAIR) is to conduct biomedical research that is responsive to Department of Defense and U.S. Army requirements and delivers lifesaving products including knowledge, technology, and medical materiel that sustain the combat effectiveness of the war fighter. Brain Trauma Neuroprotection and Neurorestoration (BTNN) Branch, Center for Military Psychiatry and Neuroscience, of the WRAIR conducts preclinical research of mild-severe traumatic brain injury (TBI), specifically the penetrating ballistic-type TBI and closed head impact concussion for the U.S. Army Medical Research and Materiel Command (USAMRMC). Research specializes in "polytrauma", accounting for the impact of hemorrhagic shock and failure to oxygenate and/or ventilate on the progression brain injury.

This research collaboration will evaluate a novel neurotherapeutic resuscitation strategy for treating TBI in the event of hemorrhagic shock during the pre-hospital phase. The findings will be the basis for future preclinical studies with delayed/long-term treatments and will provide important knowledge for future clinical studies. The research will provide insight leading to improvements in clinical practice guidelines to optimize resuscitation approaches for patients with TBI (i.e. approaches to optimize cerebral perfusion and brain salvage). Successful translation of solutions generated from the research will improve stabilization and salvage of neurologic injuries at all echelons of care.

Bid Protests Not Available